Recent Patents on Anti-Cancer Drug Discovery

Editor-in-Chief

Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)

Personal Subscription
Become EABM
Become Reviewer

Most Cited Article

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open access plus

Volume:13   Issue:2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI: 10.2174/1574892812666171129141211

PARP Inhibitors in Ovarian Cancer

Volume:13   Issue:4
Pp: 392-410
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*
DOI: 10.2174/1574892813666180305165256

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy open access plus

Volume:13   Issue:1
Pp: 86-105
Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI: 10.2174/1574892812666171108124218

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Volume:13   Issue:2
Pp: 159-183
Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin
DOI: 10.2174/1574892813666171206123114

The Application of lncRNAs in Cancer Treatment and Diagnosis

Volume:13   Issue:3
Pp: 292-301
Yi Zhang and Liling Tang*
DOI: 10.2174/1574892813666180226121819

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Volume:14   Issue:2
Pp: 113-132
Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*
DOI: 10.2174/1574892814666190514104035

PARP Inhibitors in Epithelial Ovarian Cancer open access plus

Volume:13   Issue:2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI: 10.2174/1574892813666171204094822

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy open access plus

Volume:13   Issue:1
Pp: 2-17
Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI: 10.2174/1574892812666171030163804

Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies

Volume:13   Issue:2
Pp: 224-239
Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa
DOI: 10.2174/1574892813666180213164700

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

Volume:13   Issue:1
Pp: 40-69
Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves
DOI: 10.2174/1574892812666171108115959

Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer open access plus

Volume:14   Issue:1
Pp: 39-52
Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*
DOI: 10.2174/1574892814666190102122848

Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation

Volume:13   Issue:3
Pp: 272-291
Mohit Sharma, Smitha S. Shetty and Raghu Radhakrishnan*
DOI: 10.2174/1574892813666180227103147

HMGA and Cancer: A Review on Patent Literatures

Volume:14   Issue:3
Pp: 258-267
Marco De Martino, Alfredo Fusco and Francesco Esposito*
DOI: 10.2174/1574892814666190919152001

A Truncated Snail1 Transcription Factor Alters the Expression of Essential EMT Markers and Suppresses Tumor Cell Migration in a Human Lung Cancer Cell Line

Volume:14   Issue:2
Pp: 158-169
Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*
DOI: 10.2174/1574892814666190527111429

Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents open access plus

Volume:14   Issue:1
Pp: 5-18
Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*
DOI: 10.2174/1574892814666190116111827

Recent Progress of Marine Polypeptides as Anticancer Agents

Volume:13   Issue:4
Pp: 445-454
Lanhong Zheng, Yixin Xu, Xiukun Lin*, Zhixin Yuan, Minghua Liu, Shousong Cao, Fuming Zhang and Robert J. Linhardt
DOI: 10.2174/1574892813666180430110033

NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents

Volume:13   Issue:1
Pp: 106-117
Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*
DOI: 10.2174/1574892812666171027102627

Cucurbitacins as Anticancer Agents: A Patent Review

Volume:14   Issue:2
Pp: 133-143
Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali
DOI: 10.2174/1574892813666181119123035

Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease open access plus

Volume:14   Issue:2
Pp: 144-157
Dongmei Chen, Xiao Z. Zhou* and Tae H. Lee*
DOI: 10.2174/1574892814666181218170257

New Anti-Cancer Strategies in Testicular Germ Cell Tumors open access plus

Volume:14   Issue:1
Pp: 53-59
Paolo Chieffi*, Marco De Martino and Francesco Esposito
DOI: 10.2174/1574892814666190111120023

Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors open access plus

Volume:13   Issue:4
Pp: 428-444
Zsuzsanna Suba*
DOI: 10.2174/1574892813666180720123732

Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature open access plus

Volume:13   Issue:4
Pp: 422-427
Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*
DOI: 10.2174/1574892813666180528105023